glyns answers and other things spoken about, page-26

Hi hoofa,
You do approach the process as if OBJ is to complete all these tasks themselves.
It could not be more to the contrary.
We have the multimillion marketing and developing budgets of companies like GSK, possibly Reckitt Benckiser etc to take care of these steps.
If we were to know the amount of money those majors already spent on our developments, it would send the shareprice spiraling to all time highs as it is.


OBJ is not attemtping to bring new products into the market ( with the exception of our own pain patch ), partner companies apply our technology to existing pipelines within their global ranges.
That is the beauty of OBJ's managerial approach and one of the strong reasons why I'm so heavily invested in this growth story.